Eric Dobmeier has an estimated net worth of $32.2 Million. This is based on reported shares across multiple companies, which include Adaptive Biotechnologies Corp, Atara Biotherapeutics, Inc., CHINOOK THERAPEUTICS, INC., Versartis, Inc., SEATTLE GENETICS INC /WA, Structure Therapeutics Inc., STEMLINE THERAPEUTICS INC, and Janux Therapeutics, Inc..

2007 was Eric Dobmeier's most active year for acquiring shares with 83 total transactions. Eric Dobmeier's most active month to acquire stocks was the month of August. 2007 was Eric Dobmeier's most active year for disposing of shares, totalling 156 transactions. Eric Dobmeier's most active month to dispose stocks was the month of August. 2013 saw Eric Dobmeier paying a total of $6,353,055.32 for 416,223 shares, this is the most they've acquired in one year. In 2023 Eric Dobmeier cashed out on 2,309,676 shares for a total of $51,112,349.60, their largest year based on trade value.